Summit Therapeutics Inc. ("Summit," "we," or the "Company") today reports its financial results and provides an update on clinical and operational progress for the first quarter ended March 31, 2026.

The Big 12’s five-year, multimillion-dollar private equity deal with RedBird Capital and Weatherford Capital is a major ...

Located in Glendale, this massive thrift store has become something of a legend among Arizona bargain hunters who know that ...

These forward-looking statements include, but are not limited to, statements regarding our Q2 second half of 2026 and full year 2026 guidance, expected improvements in operating and financial metrics.

Universal Display Corporation (Nasdaq: OLED), a global leader in energy-efficient OLED technologies and materials, announced today that its Board of Directors has authorized a new share repurchase ...

YoY Growth in Revenue, Earnings, and Cash Flow Increased Adjusted Diluted EPS Outlook for Completed Share Repurchases Executing on Capital ...

Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) ...

Getting a startup loan without revenue isn’t easy, but it’s possible. Here’s how to find funding, qualify and improve your ...

During King Charles III's first visit to the White House, First Lady Melania Trump and Queen Camilla spent some of Tuesday ...

Dynatrace (NYSE: DT), the leading AI-powered observability platform, today issued the following statement in response to the press release and related letter issued by Starboard Value LP ("Starboard") ...

NDA submission based on the Phase 2b REZILIENT1 clinical trial, which demonstrated clinically meaningful and durable ...

Patient was dosed at NYU Langone Health under the supervision of Dr. Alexandra Miller, Chief of Neuro-Oncology & Co-Director of Brain and Spine Tumor Center, Perlmutter Cancer CenterData ...